Skip to main content

Posts

Showing posts with the label STI patients

Determination of Sero-Prevalence of Chlamydia Trachomatis in Sti Patients | Chapter 02 | New Horizons in Medicine and Medical Research Vol. 6

 Sexually transmitted infections are most commonly caused by Chlamydia trachomatis (STIs). If undetected and untreated, chlamydial infections can have catastrophic repercussions. Patients that are infected spread the disease to their partners. The goal of this study was to determine the prevalence of genital Chlamydia and its relationship to bacterial flora in STI patients visiting STI clinics, to identify C. Trachomatis Antigen by Immunochromatography, to detect C. Trachomatis Antibody (IgG) by ELISA, and to look for possible associations between C. Trachomatis and other bacteria. Methods: Blood and genital discharge specimens (Endocervical and Vaginal) were collected from 226 patients using standard techniques. Bacterial flora were isolated and identified using traditional methods. An Immunochromatographic assay (Biomerieux) and an ELISA were used to check for the presence of Chlamydia trachomatis antigen and antibody in the patients (Novatech, Germany). Inclusion bodies were...

Determination of Epidemiological Markers and Seroprevalence of Chlamydia Trachomatis in Female Sti Attendees | Chapter 13 | New Horizons in Medicine and Medical Research Vol. 6

  The goal of this study was to establish chlamydia trachomatis seroprevalence and its relationship to several epidemiological variables. Chlamydia trachomatis is the most prevalent cause of sexually transmitted infections (STIs). Chlamydial infections that go undiagnosed and untreated might have long-term repercussions. Infected patients are a source of infection for their partners. The purpose of this study was to determine the epidemiological symptoms and seroprevalence of genital Chlamydia in female STI patients who visited STI clinics. In 226 clinically suspected cases of Sexually Transmitted Infection (STI) patients attending a STI clinic, the seroprevalence of chlamydia trachomatis, as well as age, marital status, history of sexual contact, and contraceptive use, were assessed. Patients were tested for the presence of chlamydia trachomatis IgG antibodies using an ELISA (Novatech, Germany) assay. The seroprevalence of chlamydia trachomatis IgG was found to be 55.66 percent by...